LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.
Daldegan-Bueno D, Donegan CJ, Forsyth A, Sumner RL, Murphy RJ, Menkes DB, Evans W, Hoeh N, Sundram F, Reynolds LM, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Bansal M, Muthukumaraswamy S.
Daldegan-Bueno D, et al. Among authors: hoeh n.
Trials. 2024 Aug 24;25(1):560. doi: 10.1186/s13063-024-08384-3.
Trials. 2024.
PMID: 39182140
Free PMC article.